Azopt and Calcitriol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azopt (brinzolamide) and Calcitriol (calcitriol). Common drug interactions include asthenia among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Azopt and Calcitriol. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Azopt?

Azopt has active ingredients of brinzolamide. It is often used in glaucoma. eHealthMe is studying from 8,058 Azopt users. Check the latest studies of Azopt.

What is Calcitriol?

Calcitriol has active ingredients of calcitriol. It is often used in hypoparathyroidism. eHealthMe is studying from 24,162 Calcitriol users. Check the latest studies of Calcitriol.



On Jul, 07, 2026

27 people who take Azopt and Calcitriol together, and have interactions are studied.

Azopt and Calcitriol drug interactions.

What are the common drug interactions of Azopt and Calcitriol, by gender? *:

female:

  1. Asthenia (weakness)
  2. Diarrhoea
  3. Failure to thrive (inadequate weight gain and physical growth in children)
  4. Multiple myeloma (cancer of the plasma cells)
  5. Renal failure acute (rapid kidney dysfunction)
  6. Fungal infection
  7. Fungal peritonitis (fungal infection silk like membrane lines inner abdominal wall)
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  9. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  10. Blood glucose decreased

male:

  1. Fall
  2. Upper limb fracture
  3. Muscle spasms (muscle contraction)
  4. Obstruction
  5. Peripheral swelling
  6. Chronic kidney disease
  7. Drug ineffective
  8. Dry skin
  9. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  10. Neoplasm (tumour)

What are the common drug interactions of Azopt and Calcitriol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Fungal infection
  2. Fungal peritonitis (fungal infection silk like membrane lines inner abdominal wall)

50-59:

  1. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  2. Death
  3. Diarrhoea
  4. Epistaxis (bleed from the nose)
  5. Eye discharge
  6. Nasal ulcer (ulcer of nose)
  7. Nausea (feeling of having an urge to vomit)
  8. Onychomadesis (a periodic idiopathic shedding of the nails)
  9. Oral mucosal blistering (mouth ulcer)
  10. Stomatitis (inflammation of mucous membrane of mouth)

60+:

  1. Fall
  2. Upper limb fracture
  3. Muscle spasms (muscle contraction)
  4. Obstruction
  5. Peripheral swelling
  6. Asthenia (weakness)
  7. Chronic kidney disease
  8. Failure to thrive (inadequate weight gain and physical growth in children)
  9. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  10. Multiple myeloma (cancer of the plasma cells)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 9 people, 33.33%
  2. Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 6 people, 22.22%
  3. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract): 6 people, 22.22%
  4. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 11.11%
  5. High Blood Cholesterol: 2 people, 7.41%
  6. Functional Gastrointestinal Disorder (functional problem in separate organs of gastrointestinal system): 2 people, 7.41%
  7. Diarrhea: 2 people, 7.41%
  8. Anaemia (lack of blood): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Azopt and Calcitriol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Azopt and Calcitriol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Azopt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Calcitriol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Azopt and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Calcitriol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on brinzolamide and calcitriol (the active ingredients of Azopt and Calcitriol, respectively), and Azopt and Calcitriol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: